AEQUS NSE filing

Aequs Limited Approves Preferential Issue of Warrants Worth ₹650 Crore

The RealCase readHigh impact Positive

Aequs Limited approved a preferential issue of 28,071,690 warrants to Mellwood Trustee Services Private Limited for ₹650 crore. An EGM is scheduled for October 22, 2026, for shareholder approval. Warrants are convertible into equity shares by December 31, 2027.

Why it matters

The preferential issue of ₹650 crore is a substantial amount relative to the company's size and operations, indicating a significant capital infusion that could impact its financial structure, growth prospects, and shareholder value.

The market read

The company is undertaking a significant equity fundraising of ₹650 crore through a preferential issue, which is generally viewed positively as it strengthens the company's financial position and provides capital for growth.

Aequs Limited has announced the approval of a preferential issue of up to 28,071,690 warrants, each convertible into one equity share, at an issue price of ₹231.55 per warrant. The total value of this issuance is approximately ₹6,499,999,819.50 (₹650 crore). The sole subscriber for these warrants is Mellwood Trustee Services Private Limited, acting as Trustee for Melligeri Private Family Foundation, a promoter of the company.

At the time of subscription and allotment of warrants, a minimum amount of ₹3,250,000,000 (₹325 crore) will be paid. The remaining consideration will be paid at the time of exercising the right to convert the warrants into equity shares. The relevant date for determining the floor price for this issuance was September 22, 2026. The warrants are convertible into equity shares of face value ₹10 each, with a premium of ₹221.55 per warrant.

Furthermore, the Board of Directors has approved convening an Extra-Ordinary General Meeting (EGM) on Thursday, October 22, 2026, to seek shareholder approval for this preferential issue. The meeting will be held through Video Conferencing (VC) or Other Audio Visual Means (OAVM). The warrants can be exercised for conversion into equity shares on or before December 31, 2027. If not exercised by this date, the initial ₹325 crore paid will be forfeited by the company. This preferential issue will not result in any change in the control or management of the company.

Filing to action

What to do with a filing like this

Aequs Limited filed this with the NSE as a statutory disclosure, categorised under equity fundraising. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Aequs Limited. Read the original for the full detail.

View original filing